Skip to main content
. 2012 Nov 15;12(Suppl 1):S7. doi: 10.1186/1471-2482-12-S1-S7

Table 2.

AFP and CgA levels of the subjects included in the study according to the BCLC classification

α-Fetoprotein CgA
Controls 3.8 ± 1.2 73 ± 10

Stage 0 16 ±4 96 ± 6

Stage A 24 ± 6 102 ± 10

Stage B 36 ± 8 125 ± 12

Stage C 74 ± 24 145 ± 96

Stage D 128 ± 36 210 ± 110